
Laboratory Corporation of America Holdings LH
€ 217.17
-2.56%
Quartalsbericht 2025-Q3
hinzugefügt 31.10.2025
Laboratory Corporation of America Holdings Betriebsaufwand 2011-2026 | LH
Betriebsaufwand Jährlich Laboratory Corporation of America Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 1.87 B | 1.8 B | 2.03 B | 1.81 B | 1.79 B | 1.27 B | 1.21 B | 1.2 B | 1.25 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.03 B | 1.2 B | 1.58 B |
Betriebsaufwand anderer Aktien in der Diagnostik & Forschung
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M | ||
|
Brainsway Ltd.
BWAY
|
29.2 M | $ 22.11 | 3.56 % | $ 99.4 M | ||
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | ||
|
Burning Rock Biotech Limited
BNR
|
726 M | $ 22.36 | 17.07 % | $ 241 M | ||
|
Castle Biosciences
CSTL
|
59.5 M | $ 40.61 | 1.35 % | $ 1.13 B | ||
|
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | ||
|
DarioHealth Corp.
DRIO
|
62.2 M | $ 12.13 | -10.01 % | $ 344 M | ||
|
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | ||
|
Fulgent Genetics
FLGT
|
181 M | $ 28.01 | 7.77 % | $ 847 M | ||
|
BioNano Genomics
BNGO
|
41.3 M | $ 1.6 | -0.62 % | $ 2.03 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M | ||
|
Co-Diagnostics
CODX
|
45.3 M | $ 6.03 | 5.79 % | $ 177 M | ||
|
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | ||
|
Danaher Corporation
DHR
|
6.71 B | $ 235.57 | -0.44 % | $ 172 B | ||
|
DexCom
DXCM
|
1.69 B | $ 70.1 | 0.3 % | $ 27.1 B | ||
|
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | ||
|
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | ||
|
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | ||
|
Exact Sciences Corporation
EXAS
|
2.98 B | $ 101.63 | -0.02 % | $ 18.8 B | ||
|
Mettler-Toledo International
MTD
|
1.01 B | $ 1 470.87 | -0.96 % | $ 31.2 B | ||
|
Myriad Genetics
MYGN
|
709 M | $ 6.63 | 1.69 % | $ 601 M | ||
|
CareDx, Inc
CDNA
|
484 M | $ 18.9 | 0.48 % | $ 1.02 B | ||
|
Celcuity
CELC
|
113 M | $ 109.17 | 3.95 % | $ 4.31 B | ||
|
National Research Corporation
NRC
|
38.5 M | $ 18.9 | -2.07 % | $ 464 M | ||
|
Natera
NTRA
|
258 M | $ 254.4 | 2.28 % | $ 25 B | ||
|
Anixa Biosciences
ANIX
|
9.98 M | $ 3.28 | 3.14 % | $ 105 K | ||
|
OPKO Health
OPK
|
217 M | $ 1.36 | 3.03 % | $ 944 M | ||
|
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 29.12 | 1.46 % | $ 20 B | ||
|
Precipio
PRPO
|
13.6 M | $ 23.27 | 1.26 % | $ 30.2 M | ||
|
Guardant Health
GH
|
226 M | $ 109.93 | -2.14 % | $ 13.5 B | ||
|
Personalis
PSNL
|
44.5 M | $ 9.35 | 2.19 % | $ 554 M | ||
|
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
2.94 B | $ 244.29 | 1.58 % | $ 44.3 B | ||
|
Illumina
ILMN
|
3.69 B | $ 150.14 | 2.01 % | $ 23.9 B | ||
|
Charles River Laboratories International
CRL
|
607 M | $ 216.77 | 0.31 % | $ 11.1 B | ||
|
Thermo Fisher Scientific
TMO
|
7.15 B | $ 617.15 | -0.58 % | $ 236 B | ||
|
Trinity Biotech plc
TRIB
|
28.3 M | $ 0.76 | -1.05 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
116 M | $ 36.55 | -0.87 % | $ 2.19 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 178.14 | -1.27 % | $ 19.8 B | ||
|
Biodesix
BDSX
|
106 M | $ 5.96 | -1.16 % | $ 773 M | ||
|
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
408 M | $ 202.92 | 0.71 % | $ 16.7 B | ||
|
IDEXX Laboratories
IDXX
|
1.25 B | $ 714.55 | 1.09 % | $ 58.9 B |